Showing 1,461 - 1,480 results of 104,426 for search '(( 5 ((mean decrease) OR (nn decrease)) ) OR ( 5 ((g decrease) OR (a decrease)) ))', query time: 1.96s Refine Results
  1. 1461

    Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. by Swati Biswas (73661)

    Published 2013
    “…Both 13C4 and 1D11 was used at a concentration of 25 µg/ml. TGFβ as used at a concentration of 5 ng/ml. …”
  2. 1462

    Expression of neurotrophins and their receptors was decreased in <i>Slitrk6</i>-deficient inner ear. by Kei-ichi Katayama (257931)

    Published 2009
    “…<p>(A) Real-time PCR analysis of <i>Bdnf</i>, <i>Ntf3</i>, <i>Ntrk2</i>, and <i>Ntrk3</i> in E14.5 inner ear (includes cochlear and vestibular sensory epithelia, and spiral and vestibular ganglia). …”
  3. 1463
  4. 1464
  5. 1465
  6. 1466
  7. 1467
  8. 1468
  9. 1469

    Fasting-induced decreases of lipogenic gene expression are unimpaired in Bcl6 KO mice. by Christopher R. LaPensee (571785)

    Published 2014
    “…Measurements are expressed as the mean+SE for n = fed: 9 WT, 5 KO, fasted: 5 WT, and 3 KO mice. …”
  10. 1470
  11. 1471

    Jurkat and HeLa survival decreases with increasing electric field amplitude and pulse number. by Bennett L. Ibey (357053)

    Published 2013
    “…Data points represent the average survival. (mean +/−s.e., n = 3–5).</p>…”
  12. 1472

    DHT increases whereas orchidectomy decreases the weight and cross sectional area of hindlimb muscles. by Young-Eun Yoo (323357)

    Published 2013
    “…<b>A:</b> In WT mice, DHT increased the GN weight by 7% (212.4±8.8 mg), whereas orchidectomy decreased it by 14% (171.4±9.0 mg) compared with control WT mice (198.4±5.5 mg). …”
  13. 1473
  14. 1474
  15. 1475
  16. 1476
  17. 1477
  18. 1478
  19. 1479
  20. 1480

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”